Fredun Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹1,483 cr
- P/E
- 45.45×
- ROE
- 11.73%
- Debt / equity
- 0.80
- Div yield
- 0.03%
- 52-week range
- 794.00 — 2699.00
Analysis — the numbers vs the call
- Fredun Pharma's guidance leap raises credibility questions
Mobility growth guidance nearly doubled between calls; two product launches slipped months
Fredun Pharmaceuticals Ltd.
Latest quarter · Mar 2026
Strength & growth
The timeline — 6 notes on Fredun Pharmaceuticals Ltd.
June 2026
- 12 Jun 26 · 7:30 PM IST Brief Brief · Earnings · Small cap
Fredun targets 25-30% growth in FY27, eyes ₹100 cr mobility run rate
Transcript details plans for hormonal therapies, anti-aging, and pet care platform Wagr; management targets PAT margins of 10-12% in medium term.
- 10 Jun 26 · 12:07 PM IST Brief Brief · Concalls · Small cap
Fredun pivots to pet care and physiotherapy, guides 25-30% revenue growth for FY27
New-age consumer businesses grew at 40-50% CAGR and already deliver 55% gross margins, a stark contrast to the 20% from its core pharma contract manufacturing.
May 2026
- 25 May 26 · 10:07 PM IST Brief Brief · Earnings · Small cap
Fredun Pharmaceuticals posts 60% profit jump and declares 2:1 bonus
Annual revenue climbed 40% to ₹633.3 crore as the board approved a five-fold expansion of authorised capital to support the bonus issue.
- 25 May 26 · 9:54 PM IST Brief Brief · Earnings · Small cap
Fredun Pharmaceuticals lifts profit 60% and declares 2:1 bonus
Annual profit hit ₹33.2 crore on a 40% revenue jump to ₹633 crore. The board also hiked authorised capital five-fold to ₹50 crore.
- 25 May 26 · 5:53 PM IST Brief Brief · Earnings · Small cap
Fredun Pharma's profit jumps 60%, declares 2:1 bonus
FY26 revenue rose 40% to ₹639 crore, but profit grew faster at 60%. The board proposed two new shares for every one held and a final dividend.
- 25 May 26 · 2:59 PM IST Brief Brief · Earnings · Small cap
Fredun's profit jumps 60%, board declares 2:1 bonus
FY26 revenue hit Rs. 633.3 crore, with net profit climbing to Rs. 33.2 crore. The board also proposed a final dividend of 70 paise per share.